Global Fish Skin Disease Market Growth Accelerated by Rising Aquaculture Production

Fish skin disease is one of the major health problems affecting fish production globally, as the diseases affect the external epidermis and dermis portion of fishes. Fish skin diseases damage scales, impair osmoregulation, and disrupt protective barriers, making fishes vulnerable to infections and environmental stresses. Major fish skin diseases include bacterial and fungal infections like Ich, costia, epizootic ulcerative syndrome, etc. Increasing prevalence of these diseases in aquaculture farms has boosted the demand for topical medicines, disinfectants, and therapeutants for prevention and treatment of skin diseases.

Market key trends:

Rising production from aquaculture is one of the major factors augmenting the growth of the fish skin disease market. As per FAO estimates, global aquaculture production has grown significantly from 89.2 million tons in 2016 to 114.5 million tons in 2020, accounting for approximately 56% of the total fish and shellfish for human consumption. Aquaculture is increasingly adopted as the population and fish demand grow. However, intensive cultivation practices increase disease transmission risks, stress levels in fishes, thereby promoting outbreaks of various fish skin diseases. Furthermore, trade of live fish acts as a source of pathogens transmission across geographies, challenging disease control in aquafarms. This has boosted the demand for various treatment and prevention measures including antibiotics, vaccines, and aquaculture therapeutants to curb economic losses from skin diseases in the aquaculture industry.

Segment Analysis

The global fish skin disease market is dominated by the anti-parasitic segment. Fish skin disease, especially caused by parasites such as parasitic crustaceans, protozoans, monogeneans, and digeneans, is highly prevalent among aquaculture farms across the globe. Anti-parasitic drugs like deltamines,avermectins, and praziquantel are effective in controlling these parasitic infections and form a major part of the treatment protocol prescribed by veterinarians. This makes the anti-parasitic sub-segment the leader in the global fish skin disease market with the highest revenue share.

Key Takeaways

The Global Fish Skin Disease Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The global Fish Skin Disease Market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030.

The Asia Pacific region currently dominates the global fish skin disease market and is expected to continue its dominance over the forecast period as well. Countries like China, India, Vietnam, Indonesia, and Bangladesh have large aquaculture industries and witness a high incidence of fish skin diseases in their farms. With growing demand for fish and seafood in the region, the Asia Pacific fish skin disease market is projected to grow at the fastest rate.

Key players

Key players operating in the fish skin disease market include Bayer AG, Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co., Inc., Virbac S.A., Ceva Santé Animale, Elanco Animal Health, Bimeda, Aurobindo Pharma Limited, and Teva Pharmaceutical Industries Ltd. Players like Bayer AG and Zoetis Inc. have a wide geographic presence and product portfolio for aquatic animals. They are focusing on expanding their footprints in emerging markets to leverage new opportunities.

Explore more information on this topic, Please visit - 

https://www.insightprobing.com/fish-skin-disease-market-forecasts-and-growth-analysis/ 

Explore more trending article related this topic - 

https://www.ukwebwire.com/vertical-farming-market-future-prospects-and-forecast-analysis/